Gottlieb Says User Fees Will Pay for Post-Market Surveillance Amid Shutdown

Drug Industry Daily
As the partial government shutdown neared the end of a third week, FDA Commissioner Scott Gottlieb announced via Twitter that the agency will re-allocate user fee money from drug reviews to cover post-market drug safety surveillance.

To View This Article:


Subscribe To Drug Industry Daily